- Home
- COEP vs ACXP Comparison
COEP vs ACXP Comparison
Compare COEP & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COEP
- ACXP
- Stock Information
- Founded
- COEP 2017
- ACXP 2017
- Country
- COEP United States
- ACXP United States
- Employees
- COEP N/A
- ACXP N/A
- Industry
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- ACXP Biotechnology: Pharmaceutical Preparations
- Sector
- COEP Health Care
- ACXP Health Care
- Exchange
- COEP Nasdaq
- ACXP Nasdaq
- Market Cap
- COEP 32.4M
- ACXP 9.0M
- IPO Year
- COEP N/A
- ACXP 2021
- Fundamental
- Price
- COEP $10.93
- ACXP $0.45
- Analyst Decision
- COEP
- ACXP Strong Buy
- Analyst Count
- COEP 0
- ACXP 1
- Target Price
- COEP N/A
- ACXP $12.00
- AVG Volume (30 Days)
- COEP 59.8K
- ACXP 477.1K
- Earning Date
- COEP 05-09-2025
- ACXP 03-18-2025
- Dividend Yield
- COEP N/A
- ACXP N/A
- EPS Growth
- COEP N/A
- ACXP N/A
- EPS
- COEP N/A
- ACXP N/A
- Revenue
- COEP N/A
- ACXP N/A
- Revenue This Year
- COEP N/A
- ACXP N/A
- Revenue Next Year
- COEP N/A
- ACXP N/A
- P/E Ratio
- COEP N/A
- ACXP N/A
- Revenue Growth
- COEP N/A
- ACXP N/A
- 52 Week Low
- COEP $2.31
- ACXP $0.43
- 52 Week High
- COEP $13.70
- ACXP $3.33
- Technical
- Relative Strength Index (RSI)
- COEP 52.28
- ACXP 30.04
- Support Level
- COEP $10.00
- ACXP $0.60
- Resistance Level
- COEP $11.58
- ACXP $0.67
- Average True Range (ATR)
- COEP 1.33
- ACXP 0.07
- MACD
- COEP -0.14
- ACXP -0.03
- Stochastic Oscillator
- COEP 47.60
- ACXP 6.99
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.